EconPapers    
Economics at your fingertips  
 

Leukemia inhibitory factor suppresses hepatic de novo lipogenesis and induces cachexia in mice

Xue Yang, Jianming Wang, Chun-Yuan Chang, Fan Zhou, Juan Liu, Huiting Xu, Maria Ibrahim, Maria Gomez, Grace L. Guo, Hao Liu, Wei-Xing Zong, Fredric E. Wondisford, Xiaoyang Su, Eileen White, Zhaohui Feng () and Wenwei Hu ()
Additional contact information
Xue Yang: Rutgers University
Jianming Wang: Rutgers University
Chun-Yuan Chang: Rutgers University
Fan Zhou: Rutgers University
Juan Liu: Rutgers University
Huiting Xu: Rutgers-Robert Wood Johnson Medical School
Maria Ibrahim: Rutgers University
Maria Gomez: Rutgers University
Grace L. Guo: Rutgers University
Hao Liu: Rutgers School of Public Health
Wei-Xing Zong: Rutgers University
Fredric E. Wondisford: Rutgers-Robert Wood Johnson Medical School
Xiaoyang Su: Rutgers-Robert Wood Johnson Medical School
Eileen White: Rutgers University
Zhaohui Feng: Rutgers University
Wenwei Hu: Rutgers University

Nature Communications, 2024, vol. 15, issue 1, 1-15

Abstract: Abstract Cancer cachexia is a systemic metabolic syndrome characterized by involuntary weight loss, and muscle and adipose tissue wasting. Mechanisms underlying cachexia remain poorly understood. Leukemia inhibitory factor (LIF), a multi-functional cytokine, has been suggested as a cachexia-inducing factor. In a transgenic mouse model with conditional LIF expression, systemic elevation of LIF induces cachexia. LIF overexpression decreases de novo lipogenesis and disrupts lipid homeostasis in the liver. Liver-specific LIF receptor knockout attenuates LIF-induced cachexia, suggesting that LIF-induced functional changes in the liver contribute to cachexia. Mechanistically, LIF overexpression activates STAT3 to downregulate PPARα, a master regulator of lipid metabolism, leading to the downregulation of a group of PPARα target genes involved in lipogenesis and decreased lipogenesis in the liver. Activating PPARα by fenofibrate, a PPARα agonist, restores lipid homeostasis in the liver and inhibits LIF-induced cachexia. These results provide valuable insights into cachexia, which may help develop strategies to treat cancer cachexia.

Date: 2024
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/s41467-024-44924-w Abstract (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:natcom:v:15:y:2024:i:1:d:10.1038_s41467-024-44924-w

Ordering information: This journal article can be ordered from
https://www.nature.com/ncomms/

DOI: 10.1038/s41467-024-44924-w

Access Statistics for this article

Nature Communications is currently edited by Nathalie Le Bot, Enda Bergin and Fiona Gillespie

More articles in Nature Communications from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().

 
Page updated 2025-03-19
Handle: RePEc:nat:natcom:v:15:y:2024:i:1:d:10.1038_s41467-024-44924-w